These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 25083209)
21. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses. Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771 [TBL] [Abstract][Full Text] [Related]
22. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. Alvarez N; Besag F; Iivanainen M J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426 [TBL] [Abstract][Full Text] [Related]
23. Treatment of partial seizures in childhood : an overview. Coppola G CNS Drugs; 2004; 18(3):133-56. PubMed ID: 14871158 [TBL] [Abstract][Full Text] [Related]
24. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083 [TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of add-on therapy with newer-generation antiepileptic drugs in Bulgarian patients with refractory epilepsy. Viteva E; Zahariev Z Epilepsy Behav; 2018 Oct; 87():137-145. PubMed ID: 30097339 [TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Perucca E Fundam Clin Pharmacol; 2001 Dec; 15(6):405-17. PubMed ID: 11860529 [TBL] [Abstract][Full Text] [Related]
27. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971 [TBL] [Abstract][Full Text] [Related]
28. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F; Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822 [TBL] [Abstract][Full Text] [Related]
30. Treatment of epilepsy in the new millennium. Pellock JM Pharmacotherapy; 2000 Aug; 20(8 Pt 2):129S-138S. PubMed ID: 10937812 [TBL] [Abstract][Full Text] [Related]
34. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
35. Use of second-generation antiepileptic drugs in the pediatric population. Chung AM; Eiland LS Paediatr Drugs; 2008; 10(4):217-54. PubMed ID: 18590343 [TBL] [Abstract][Full Text] [Related]
36. New antiepileptic drug therapies. Bergin AM; Connolly M Neurol Clin; 2002 Nov; 20(4):1163-82. PubMed ID: 12616686 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821 [TBL] [Abstract][Full Text] [Related]
38. The new antiepileptic drugs: pharmacological and clinical aspects. Gatti G; Bonomi I; Jannuzzi G; Perucca E Curr Pharm Des; 2000 May; 6(8):839-60. PubMed ID: 10828310 [TBL] [Abstract][Full Text] [Related]
39. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Park EL; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J Epilepsy Curr; 2018; 18(4):260-268. PubMed ID: 30254527 [No Abstract] [Full Text] [Related]